ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Diphtheria

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

Top
 Next
See Images

CLINICAL MANIFESTATIONS

Respiratory diphtheria usually occurs as membranous nasopharyngitis or obstructive laryngotracheitis. Local infections are associated with a low-grade fever and gradual onset of manifestations over 1 to 2 days. Less commonly, diphtheria presents as cutaneous, vaginal, conjunctival, or otic infection. Cutaneous diphtheria is more common in tropical areas and among the urban homeless. Serious complications of diphtheria include severe neck swelling (bull neck) accompanying upper airway obstruction caused by extensive membrane formation, myocarditis, and peripheral neuropathies.


Top
 Previous
Next
See Images

ETIOLOGY

Diphtheria is caused by toxigenic strains of Corynebacterium diphtheriae; rarely, a diphtheria-like illness is caused by toxigenic strains of Corynebacterium ulcerans. C diphtheriae is an irregularly staining, gram-positive, nonspore-forming, nonmotile, pleomorphic bacillus with 4 biotypes (mitis, intermedius, belfanti, and gravis). All biotypes of C diphtheriae may be either toxigenic or nontoxigenic. Toxigenic strains express an exotoxin that consists of an enzymatically active A domain and a binding B domain, which promotes the entry of A into the cell. The toxin gene, tox, is carried by a family of related corynebacteria phages. The toxin inhibits protein synthesis in all cells, including myocardial, renal, and peripheral nerve cells, resulting in myocarditis, acute tubular necrosis, and delayed peripheral nerve conduction. Nontoxigenic strains of C diphtheriae can cause sore throat and other invasive infections, including endocarditis.


Top
 Previous
Next
See Images

EPIDEMIOLOGY

Humans are the sole reservoir of C diphtheriae. The organisms are spread by respiratory tract droplets and by contact with discharges from skin lesions. In untreated people, organisms can be present in discharges from the nose and throat and from eye and skin lesions for 2 to 6 weeks after infection. Patients treated with an appropriate antimicrobial agent usually are communicable for fewer than 4 days. . . . [Go to Full Text]


Related text in Red Book:

Scheduling Immunizations

Red Book 2009: 21-31. [Extract] [Full Version]  

Antibodies of Animal Origin (Animal Antisera)

Red Book 2009: 61-65. [Extract] [Full Version]  

Immunizations

Red Book 2009: 183-184. [Extract] [Full Version]  

Tetanus (Lockjaw)

Red Book 2009: 655-660. [Extract] [Full Version]  

Pertussis (Whooping Cough)

Red Book 2009: 504-519. [Extract] [Full Version]  

Appendix I. Directory of Resources

Red Book 2009: 831-834. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Groom, A. V., Washington, M. L., Smith, P. J., Bryan, R. T. (2008). Underimmunization of American Indian and Alaska Native Children. Pediatrics 121: 938-944 [Abstract] [Full Version]  
  • Allred, N. J., Wooten, K. G., Kong, Y. (2007). The Association of Health Insurance and Continuous Primary Care in the Medical Home on Vaccination Coverage for 19- to 35-Month-Old Children. Pediatrics 119: S4-S11 [Abstract] [Full Version]  
  • Guerra, F. A., Blatter, M. M., Greenberg, D. P., Pichichero, M., Noriega, F. R., on behalf of the Pentacel Study Group, (2009). Safety and Immunogenicity of a Pentavalent Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in US Infants and Toddlers and Persistence of Antibodies Before a Preschool Booster Dose: A Randomized, Clinical Trial. Pediatrics 123: 301-312 [Abstract] [Full Version]  
  • Ward, K. N., Bryant, N. J., Andrews, N. J., Bowley, J. S., Ohrling, A., Verity, C. M., Ross, E. M., Miller, E. (2007). Risk of Serious Neurologic Disease After Immunization of Young Children in Britain and Ireland. Pediatrics 120: 314-321 [Abstract] [Full Version]  
  • Shinall, M. C. Jr, Peters, T. R., Zhu, Y., Chen, Q., Poehling, K. A. (2008). Potential Impact of Acceleration of the Pertussis Vaccine Primary Series for Infants. Pediatrics 122: 1021-1026 [Abstract] [Full Version]  
  • Fishbein, D. B., Broder, K. R., Markowitz, L., Messonnier, N. (2008). New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent. Pediatrics 121: S5-S14 [Abstract] [Full Version]  
  • Spergel, J. M. (2006). Long-term Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% in Infants Does Not Interfere With the Development of Protective Antibodies After Vaccination. Pediatrics 118: S15-S16 [Abstract]  
  • McCauley, M. M., Fishbein, D. B., Santoli, J. M. (2008). Introduction: Strengthening the Delivery of New Vaccines for Adolescents. Pediatrics 121: S1-S4 [Full Version]  
  • Bonilla, F. A. (2007). Infants Presenting With Recurrent Infections and Low Immunoglobulins: Characteristics and Analysis of Normalization. Pediatrics 120: S156-S157 [Abstract]  
  • Batra, J. S., Eriksen, E. M., Zangwill, K. M., Lee, M., Marcy, S. M., Ward, J. I., for the Vaccine Safety Datalink, (2009). Evaluation of Vaccine Coverage for Low Birth Weight Infants During the First Year of Life in a Large Managed Care Population. Pediatrics 123: 951-958 [Abstract] [Full Version]  
  • Kummeling, I., Thijs, C., Stelma, F., Huber, M., van den Brandt, P. A., Dagnelie, P. C. (2007). Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life: The KOALA Birth Cohort Study. Pediatrics 119: e367-e373 [Abstract] [Full Version]  
  • Dennehy, P. H., Bertrand, H. R., Silas, P. E., Damaso, S., Friedland, L. R., Abu-Elyazeed, R. (2008). Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States. Pediatrics 122: e1062-e1066 [Abstract] [Full Version]  
  • Goldsobel, A. B. (2007). Clinical and Laboratory Characteristics of 75 Patients With Specific Polysaccharide Antibody Deficiency Syndrome. Pediatrics 120: S157-S158 [Abstract]  
  • Kewalramani, A., Bollinger, M. E. (2007). Clinical Effects of Probiotics Are Associated With Increased Interferon-{gamma} Responses in Very Young Children With Atopic Dermatitis. Pediatrics 120: S124-S124 [Abstract]  
  • Smith, P. J., Kennedy, A. M., Wooten, K., Gust, D. A., Pickering, L. K. (2006). Association Between Health Care Providers' Influence on Parents Who Have Concerns About Vaccine Safety and Vaccination Coverage. Pediatrics 118: e1287-e1292 [Abstract] [Full Version]  
  • Dylag, A. M., Shah, S. I. (2008). Administration of Tetanus, Diphtheria, and Acellular Pertussis Vaccine to Parents of High-Risk Infants in the Neonatal Intensive Care Unit. Pediatrics 122: e550-e555 [Abstract] [Full Version]  
  • Zangwill, K. M., Eriksen, E., Lee, M., Lee, J., Marcy, S. M., Friedland, L. R., Weston, W., Howe, B., Ward, J. I. (2008). A Population-Based, Postlicensure Evaluation of the Safety of a Combination Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine in a Large Managed Care Organization. Pediatrics 122: e1179-e1185 [Abstract] [Full Version]